Dr. Philip B. Dattilo III, MD

Dr. Dattilo practices at UCHealth Medical Group in Loveland, Colorado.

Dr. Dattilo's NPI, 1245452994, was assigned on May 3, 2007. Dr. Dattilo graduated from Albert Einstein College of Medicine in 2001. Dr. Dattilo holds Colorado license DR.0047426.

Dr. Dattilo's primary practice is UCHealth Medical Group, at 2695 Rocky Mountain Ave, Loveland, CO 80538 in Larimer County. The practice phone is (970) 624-4420.

Dr. Dattilo's primary practice is UCHealth Medical Group in Loveland, Colorado. Dr. Dattilo is also affiliated with UCHealth Medical Center of the Rockies. The medical group on file is UCHealth Medical Group. Dmand AI also links Dr. Dattilo to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Dattilo practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Dattilo's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Dattilo is board certified in cardiovascular disease by the American Board of Internal Medicine. Dmand AI has Dr. Dattilo's licenses on file in 6 states: Colorado, Nebraska, Wyoming, Utah, Washington and New York.

Dmand AI lists angioplasty, cardiac catheterization, circulation problems and endocarditis among the conditions Dr. Dattilo treats.

CMS data shows 2,517 Medicare services from Dr. Dattilo across 29 procedure codes in 2024, for 1,595 Medicare patients. Medicare paid $157,056 for them.

CMS counts 1,595 Medicare patients who saw Dr. Dattilo in 2024. The largest group is 75 to 84, with 653 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.41, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Dattilo's median patient age at 76, with 44% women.

In 2024, Dr. Dattilo wrote 4,747 Medicare Part D claims for 690 patients. 84% of them were for generic drugs. CMS names the drug for 4,483 of them, across 38 drugs with 11 or more claims each, at $943,357 in total drug cost. In 2023, CMS named 3,553 claims across 32 drugs.

Dr. Dattilo accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Dattilo as offering telehealth. CMS counts 36 procedures of coronary angioplasty and stenting by Dr. Dattilo, more than 72% of the clinicians it reports for that procedure.

Dmand AI links 18 papers to Dr. Dattilo, published from 2011 to 2024. 2013 was the busiest year, with 2. The most frequent topics are Percutaneous Coronary Intervention, Coronary Angiography and Coronary Occlusion. Dr. Dattilo has published most often in Catheter Cardiovasc Interv. Dr. Dattilo's most frequent co-authors are Khaldoon Alaswad, MD, Ivan Casserly, MD and Rhian Elizabeth Davies, DO.

Dmand AI links Dr. Dattilo to 1 clinical trial. Conditions studied include Peripheral Arterial Disease and Peripheral Vascular Diseases.

CMS Open Payments shows 17 general payments to Dr. Dattilo from 11 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Medtronic Vascular, Inc. paid the most, $301.

Dr. Dattilo graduated from Albert Einstein College of Medicine in 2001. Dr. Dattilo is a member of ACC.

Dr. Dattilo is in network with 19 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.